Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Ionis Pharmaceuticals

Ionis Pharmaceuticals reported $143K in Ordinary Share Capital for its fiscal quarter ending in March of 2023.

Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US USD 72K 1000
Alnylam Pharmaceuticals ALNY:US USD 1.24M 3K
Arrowhead Research ARWR:US USD 199K 0
Astellas Pharma 4503:JP JPY 103B 0
BioMarin Pharmaceutical BMRN:US USD 188K 2K
Bluebird Bio BLUE:US USD 1.06M 234K
Esperion Therapeutics ESPR:US USD 87K 12K
Exelixis EXEL:US USD 325K 1000
Halozyme Therapeutics HALO:US USD 132K 3K
Intercept Pharmaceuticals ICPT:US USD 42K 0
Mirati Therapeutics MRTX:US USD 58K 0
Moderna Inc MRNA:US USD 38.4K 100
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NOVN:VX USD 842M 48M
PTC Therapeutics PTCT:US USD 73K 1000
Roche Holding ROG:VX CHF 107M 0
Sarepta Therapeutics SRPT:US USD 9K 0
Ultragenyx Pharmaceutical RARE:US USD 71K 1000
Vertex Pharmaceuticals VRTX:US USD 2.6M 0